|
| |
|
| |
| EDITOR:
|
Neil Love, MD
Neil Love, MD |
| |
|
| FEATURING: |
Judd W Moul, MD, FACS |
| |
Evaluation and management of a patient
with PSA recurrence
Natural history of a PSA recurrence following radical
prostatectomy
Timing of hormonal therapy
Center for Prostate Disease Research (CPDR) database
Traditional versus nontraditional hormonal therapy
Adjuvant hormonal therapy
Select
publications |
| |
|
| |
Craig D Zippe, MD |
| |
Postprostatectomy erectile dysfunction
Nerve-sparing radical prostatectomy
Postoperative management of erectile function
Therapeutic options for erectile dysfunction
Evaluation of erectile function
CASE 1: 76-year-old man with Gleason 7 prostate cancer
Select publications
|
| |
|
| |
Anthony V D’Amico,
MD, PhD |
| |
Brachytherapy
Adjuvant hormonal therapy
Higher radiation doses
The Surgical Prostatectomy versus Interstitial Radiation
Intervention Trial (SPIRIT)
Hormonal therapy in combination with radiation therapy
Patients with low-risk prostate cancer
Managing PSA recurrence after radiation therapy
Early versus delayed hormonal therapy
PSA doubling time as a predictor of survival
Initiating hormonal therapy at PSA recurrence
Select publications
|
| |
|
| |
Anna C Ferrari, MD |
| |
Consultation with patients presenting with adverse prognostic
factors
Lymph node micrometastases in patients with prostate
cancer
PSA recurrence – local or systemic disease?
Prostate Cancer Journal Club
- Androgen receptor signaling in androgen-refractory
prostate cancer
- Evidence for the differential expression of a variant
EGF receptor in human prostate cancer
- Bicalutamide monotherapy compared with castration
in patients with nonmetastatic locally advanced prostate
cancer: 6.3 years of follow-up
CASE 2: 61-year-old man with Gleason 8, hormone-independent,
prostate cancer
Select publications |
| |
|
|
|
|
|
|
